Related references
Note: Only part of the references are listed.Geographic and Clinical Variation in Clozapine Use in the United States
T. Scott Stroup et al.
PSYCHIATRIC SERVICES (2014)
Classics in Chemical Neuroscience: Clozapine
Cody J. Wenthur et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
Stefan Leucht et al.
LANCET (2013)
A Systematic Review and Meta-Analysis of Recovery in Schizophrenia
Erika Jaaskelainen et al.
SCHIZOPHRENIA BULLETIN (2013)
Risk of neutropenia in a clozapine-treated elderly population
Melanie D. Guenette et al.
SCHIZOPHRENIA RESEARCH (2013)
Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study
Marc De Hert et al.
SCHIZOPHRENIA RESEARCH (2010)
The Elderly Safety Imperative and Antipsychotic Usage
Lama M. Chahine et al.
HARVARD REVIEW OF PSYCHIATRY (2010)
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
Jari Tiihonen et al.
LANCET (2009)
Hospitalization Risk Associated with Typical and Atypical Antipsychotic Use in Community-Dwelling Elderly Patients
Rajender R. Aparasu et al.
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2008)
The safety of clozapine in the elderly
Pietro Gareri et al.
EXPERT OPINION ON DRUG SAFETY (2008)
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment
JP McEvoy et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Share Paper
